| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.0M | +85.7% |
| R&D Expense | $74.0M | +15.3% |
| SG&A Expense | $20.0M | +56.9% |
| Operating Income | -$81.1M | -15.8% |
| Pre-tax Income | -$68.9M | -0.8% |
| Income Tax | $0 | — |
| Net Income | -$68.9M | -3.1% |
| EPS (Basic) | -$11.22 | +75.2% |
| EPS (Diluted) | -$11.22 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.1M | +171.1% |
| Short-term Investments | $105.1M | +88.5% |
| Current Assets | $153.5M | +107.4% |
| Total Assets | $224.9M | +195.8% |
| Current Liabilities | $17.9M | -36.0% |
| Total Liabilities | $19.4M | -32.0% |
| Stockholders' Equity | $205.6M | +242.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$76.4M | -31.4% |
| Capital Expenditures | $235K | +167.0% |
| Investing Cash Flow | -$115.3M | -2787.7% |
| Financing Cash Flow | $220.8M | +346.7% |
| Free Cash Flow | -$76.7M | -31.6% |
| +75.2% |